The ASX is home to some very long-term performers in the healthcare sector - think CSR and Cochlear - as well as some more recent arrivals.

Steve Wheen, Managing Director, Equity Research at Jarden, talks to Sean Aylmer about the opportunities he sees within healthcare stocks in Australia.

This is Fear & Greed's summer investing series. All information is general in nature - you should seek independent professional advice before making investment decisions.